|
1
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guilmeau S: Notch signaling and intestinal
cancer. Adv Exp Med Biol. 727:272–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Morell CM and Strazzabosco M: Notch
signaling and new therapeutic options in liver disease. J Hepatol.
60:885–890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brzozowa-Zasada M, Piecuch A, Dittfeld A,
Mielańczyk Ł, Michalski M, Wyrobiec G, Harabin-Słowińska M, Kurek J
and Wojnicz R: Notch signalling pathway as an oncogenic factor
involved in cancer development. Contemp Oncol (Pozn). 20:267–272.
2016.PubMed/NCBI
|
|
5
|
Azemar M, Schmidt M, Arlt F, Kennel P,
Brandt B, Papadimitriou A, Groner B and Wels W: Recombinant
antibody toxins specific for ErbB2 and EGF receptor inhibit the in
vitro growth of human head and neck cancer cells and cause rapid
tumor regression in vivo. Int J Cancer. 86:269–275. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khurana E, Fu Y, Chakravarty D, Demichelis
F, Rubin MA and Gerstein M: Role of non-coding sequence variants in
cancer. Nat Rev Genet. 17:93–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hayes EL and Lewis-Wambi JS: Mechanisms of
endocrine resistance in breast cancer: An overview of the proposed
roles of noncoding RNA. Breast Cancer Res. 17:402015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bu P, Chen KY, Chen JH, Wang L, Walters J,
Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A
microRNA miR-34a-regulated bimodal switch targets Notch in colon
cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S
and Sarkar FH: Cross-talk between miRNA and Notch signaling
pathways in tumor development and progression. Cancer Lett.
292:141–148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Wu P, Lin R, Rong L, Xue Y and
Fang Y: LncRNA NALT interaction with NOTCH1 promoted cell
proliferation in pediatric T cell acute lymphoblastic leukemia. Sci
Rep. 5:137492015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Katsushima K, Natsume A, Ohka F, Shinjo K,
Hatanaka A, Ichimura N, Sato S, Takahashi S, Kimura H, Totoki Y, et
al: Targeting the Notch-regulated non-coding RNA TUG1 for glioma
treatment. Nat Commun. 7:136162016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mo YY, Tang H and Miele L:
Notch-associated microRNAs in cancer. Curr Drug Targets.
14:1157–1166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kopan R and Ilagan MX: The canonical Notch
signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miele L: Notch signaling. Clin Cancer Res.
12:1074–1079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mizutani T, Taniguchi Y, Aoki T, Hashimoto
N and Honjo T: Conservation of the biochemical mechanisms of signal
transduction among mammalian Notch family members. Proc Natl Acad
Sci USA. 98:pp. 9026–9031. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chitnis A and Balle-Cuif L: The Notch
meeting: An odyssey from structure to function. Development.
143:547–553. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pakkiriswami S, Couto A, Nagarajan U and
Georgiou M: Glycosylated Notch and Cancer. Front Oncol. 6:372016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Djiane A, Krejci A, Bernard F, Fexova S,
Millen K and Bray SJ: Dissecting the mechanisms of Notch induced
hyperplasia. EMBO J. 32:60–71. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Halaoui R and McCaffrey L: Rewiring cell
polarity signaling in cancer. Oncogene. 34:939–950. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andersson ER, Sandberg R and Lendahl U:
Notch signaling: Simplicity in design, versatility in function.
Development. 138:3593–3612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dominguez M: Oncogenic programmes and
Notch activity: An ‘organized crime’? Semin Cell Dev Biol.
28:78–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suh DH, Kim TH, Kim JW, Kim SY, Kim HS,
Lee TS, Chung HH, Kim YB, Park NH and Song YS: Improvements to the
FIGO staging for ovarian cancer: Reconsideration of lymphatic
spread and intraoperative tumor rupture. J Gynecol Oncol.
24:352–358. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leong KG, Niessen K, Kulic I, Raouf A,
Eaves C, Pollet I and Karsan A: Jagged1-mediated Notch activation
induces epithelial-to-mesenchymal transition through Slug-induced
repression of E-cadherin. J Exp Med. 204:2935–2948. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meng RD, Shelton CC, Li YM, Qin LX,
Notterman D, Paty PB and Schwartz GK: gamma-Secretase inhibitors
abrogate oxaliplatin-induced activation of the Notch-1 signaling
pathway in colon cancer cells resulting in enhanced
chemosensitivity. Cancer Res. 69:573–582. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Li Y, Kong D, Banerjee S, Ahmad A,
Azmi AS, Ali S, Abbruzzese JL, Gallick GE and Sarkar FH:
Acquisition of epithelial-mesenchymal transition phenotype of
gemcitabine-resistant pancreatic cancer cells is linked with
activation of the notch signaling pathway. Cancer Res.
69:2400–2407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Umemura T and Kuroki C: Circulating
MicroRNAs as biomarkers of colorectal cancer. Rinsho Byori.
63:336–346. 2015.(In Japanese). PubMed/NCBI
|
|
31
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nouraee N, Khazaei S, Vasei M, Razavipour
SF, Sadeghizadeh M and Mowla SJ: MicroRNAs contribution in tumor
microenvironment of esophageal cancer. Cancer Biomark. 16:367–376.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu C, Duan P, Li B, Huang C, Jing Y and
Yan W: miR-29a activates Hes1 by targeting Nfia in esophageal
carcinoma cell line TE-1. Oncol Lett. 9:96–102. 2015.PubMed/NCBI
|
|
35
|
Ohashi S, Natsuizaka M, Naganuma S, Kagawa
S, Kimura S, Itoh H, Kalman RA, Nakagawa M, Darling DS, Basu D, et
al: A NOTCH3-mediated squamous cell differentiation program limits
expansion of EMT-competent cells that express the ZEB transcription
factors. Cancer Res. 71:6836–6847. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Piazzi G, Fini L, Selgrad M, Garcia M,
Daoud Y, Wex T, Malfertheiner P, Gasbarrini A, Romano M, Meyer RL,
et al: Epigenetic regulation of delta-like1 controls Notch1
activation in gastric cancer. Oncotarget. 2:1291–1301. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang G, Gong Y, Wang Q, Wang Y and Zhang
X: The role of miR-100-mediated Notch pathway in apoptosis of
gastric tumor cells. Cell Signal. 27:1087–1101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ji Q, Hao X, Meng Y, Zhang M, Desano J,
Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits
human p53-mutant gastric cancer tumorspheres. BMC Cancer.
8:2662008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brzozowa M, Mielańczyk L, Michalski M,
Malinowski L, Kowalczyk-Ziomek G, Helewski K, Harabin-Słowińska M
and Wojnicz R: Role of Notch signaling pathway in gastric cancer
pathogenesis. Contemp Oncol (Pozn). 17:1–5. 2013.PubMed/NCBI
|
|
40
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li H, Xie S, Liu M, Chen Z, Liu X, Wang L,
Li D and Zhou Y: The clinical significance of downregulation of
mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric
cancer tumorigenesis. Int J Oncol. 45:197–208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hashimoto Y, Akiyama Y, Otsubo T, Shimada
S and Yuasa Y: Involvement of epigenetically silenced microRNA-181c
in gastric carcinogenesis. Carcinogenesis. 31:777–784. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yan C, Yu J, Kang W, Liu Y, Ma Z and Zhou
L: miR-935 suppresses gastric signet ring cell carcinoma
tumorigenesis by targeting Notch1 expression. Biochem Biophys Res
Commun. 470:68–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Weng MT, Tsao PN, Lin HL, Tung CC, Change
MC, Chang YT, Wong JM and Wei SC: Hes1 increases the invasion
ability of colorectal cancer cells via the STAT3-MMP14 pathway.
PLoS One. 10:e01443222015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Furukawa S, Kawasaki Y, Miyamoto M,
Hiyoshi M, Kitayama J and Akiyama T: The miR-1-NOTCH3-Asef pathway
is important for colorectal tumor cell migration. PLoS One.
8:e806092013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Xiong Y, Zhang YY, Wu YY, Wang XD, Wan LH,
Li L and Zhou LM: Correlation of over-expressions of miR-21 and
Notch-1 in human colorectal cancer with clinical stages. Life Sci.
106:19–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Roy S, Levi E, Majumdar AP and Sarkar FH:
Expression of miR-34 is lost in colon cancer which can be
re-expressed by a novel agent CDF. J Hematol Oncol. 5:582012.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bae Y, Yang T, Zeng HC, Campeau PM, Chen
Y, Bertin T, Dawson BC, Munivez E, Tao J and Lee BH: miRNA-34c
regulates Notch signaling during bone development. Hum Mol Genet.
21:2991–3000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Iwaya T, Yokobori T, Nishida N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Downregulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sureban SM, May R, Mondalek FG, Qu D,
Ponnurangam S, Pantazis P, Anant S, Ramanujam RP and Houchen CW:
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144
and inhibits colorectal cancer tumor growth via a Notch-1 dependent
mechanism. J Nanobiotechnology. 9:402011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Vickers MM, Bar J, Gorn-Hondermann I,
Yarom N, Daneshmand M, Hanson JE, Addison CL, Asmis TR, Jonker DJ,
Maroun J, et al: Stage-dependent differential expression of
microRNAs in colorectal cancer: Potential role as markers of
metastatic disease. Clin Exp Metastasis. 29:123–132. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang L, Liu X, Jin H, Guo X, Xia L, Chen
Z, Bai M, Liu J, Shang X, Wu K, et al: miR-206 inhibits gastric
cancer proliferation in part by repressing cyclinD2. Cancer Lett.
332:94–101. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Song G, Zhang Y and Wang L: MicroRNA-206
targets notch3, activates apoptosis, and inhibits tumor cell
migration and focus formation. J Biol Chem. 284:31921–31927. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gagan J, Dey BK, Layer R, Yan Z and Dutta
A: Notch3 and Mef2c proteins are mutually antagonistic via Mkp1
protein and miR-1/206 microRNAs in differentiating myoblasts. J
Biol Chem. 287:40360–40370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang XW, Xi XQ, Wu J, Wan YY, Hui HX and
Cao XF: MicroRNA-206 attenuates tumor proliferation and migration
involving the downregulation of NOTCH3 in colorectal cancer. Oncol
Rep. 33:1402–1410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Maemura K, Natsugoe S and Takao S:
Molecular mechanism of cholangiocarcinoma carcinogenesis. J
Hepatobiliary Pancreat Sci. 21:754–760. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Jung KH, Zhang J, Zhou C, Shen H, Gagea M,
Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK and Beretta L:
Differentiation therapy for hepatocellular carcinoma: Multifaceted
effects of miR-148a on tumor growth and phenotype and liver
fibrosis. Hepatology. 63:864–879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Liu M, Lee DF, Chen CT, Yen CJ, Li LY, Lee
HJ, Chang CJ, Chang WC, Hsu JM, Kuo HP, et al: IKKα activation of
NOTCH links tumorigenesis via FOXA2 suppression. Mol Cell.
45:171–184. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Westhoff B, Colaluca IN, D'Ario G,
Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G,
Viale G, et al: Alterations of the Notch pathway in lung cancer.
Proc Natl Acad Sci USA. 106:pp. 22293–22298. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Karaczyn A, Bani-Yaghoub M, Tremblay R,
Kubu C, Cowling R, Adams TL, Prudovsky I, Spicer D, Friesel R, Vary
C and Verdi JM: Two novel human NUMB isoforms provide a potential
link between development and cancer. Neural Dev. 5:312010.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Gramantieri L, Giovannini C, Lanzi A,
Chieco P, Ravaioli M, Venturi A, Grazi GL and Bolondi L: Aberrant
Notch3 and Notch4 expression in human hepatocellular carcinoma.
Liver Int. 27:997–1007. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Liu W, Xu C, Wan H, Liu C, Wen C, Lu H and
Wan F: MicroRNA-206 overexpression promotes apoptosis, induces cell
cycle arrest and inhibits the migration of human hepatocellular
carcinoma HepG2 cells. Int J Mol Med. 34:420–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Giovannini C, Gramantieri L, Minguzzi M,
Fornari F, Chieco P, Grazi GL and Bolondi L: CDKN1C/P57 is
regulated by the Notch target gene Hes1 and induces senescence in
human hepatocellular carcinoma. Am J Pathol. 181:413–422. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Giovannini C, Minguzzi M, Baglioni M,
Fornari F, Giannone F, Ravaioli M, Cescon M, Chieco P, Bolondi L
and Gramantieri L: Suppression of p53 by Notch3 is mediated by
cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular
carcinoma. Oncotarget. 5:10607–10620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Fornari F, Milazzo M, Galassi M, Callegari
E, Veronese A, Miyaaki H, Sabbioni S, Mantovani V, Marasco E,
Chieco P, et al: p53/mdm2 feedback loop sustains miR-221 expression
and dictates the response to anticancer treatments in
hepatocellular carcinoma. Mol Cancer Res. 12:203–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad
A, Banerjee S, Azmi AS, Miele L and Sarkar FH: Notch-1 induces
epithelial-mesenchymal transition consistent with cancer stem cell
phenotype in pancreatic cancer cells. Cancer Lett. 307:26–36. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Arslan AA, Helzlsouer KJ, Kooperberg C,
Shu XO, Steplowski E, Bueno-de-Mesquita HB, Fuchs CS, Gross MD,
Jacobs EJ, Lacroix AZ, et al: Anthropometric measures, body mass
index, and pancreatic cancer: A pooled analysis from the Pancreatic
Cancer Cohort Consortium (PanScan). Arch Intern Med. 170:791–802.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Plentz R, Park JS, Rhim AD, Abravanel D,
Hezel AF, Sharma SV, Gurumurthy S, Deshpande V, Kenific C,
Settleman J, et al: Inhibition of gamma-secretase activity inhibits
tumor progression in a mouse model of pancreatic ductal
adenocarcinoma. Gastroenterology. 136:1741–1749.e6. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Avila JL and Kissil JL: Notch signaling in
pancreatic cancer: Oncogene or tumor suppressor? Trends Mol Med.
19:320–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ji Q, Hao X, Zhang M, Tang W, Yang M, Li
L, Xiang D, Desano JT, Bommer GT, Fan D, et al: MicroRNA miR-34
inhibits human pancreatic cancer tumor-initiating cells. PLoS One.
4:e68162009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Cifarelli V, Lashinger LM, Devlin KL,
Dunlap SM, Huang J, Kaaks R, Pollak MN and Hursting SD: Metformin
and rapamycin reduce pancreatic cancer growth in obese prediabetic
mice by distinct microRNA-regulated mechanisms. Diabetes.
64:1632–1642. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Sureban SM, May R, Lightfoot SA, Hoskins
AB, Lerner M, Brackett DJ, Postier RG, Ramanujam R, Mohammed A, Rao
CV, et al: DCAMKL-1 regulates epithelial-mesenchymal transition in
human pancreatic cells through a miR-200a-dependent mechanism.
Cancer Res. 71:2328–2338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wang Z, Banerjee S, Ahmad A, Li Y, Azmi
AS, Gunn JR, Kong D, Bao B, Ali S, Gao J, et al: Activated K-ras
and INK4a/Arf deficiency cooperate during the development of
pancreatic cancer by activation of Notch and NF-κB signaling
pathways. PLoS One. 6:e205372011. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Brabletz S, Bajdak K, Meidhof S, Burk U,
Niedermann G, Firat E, Wellner U, Dimmler A, Faller G, Schubert J
and Brabletz T: The ZEB1/miR-200 feedback loop controls Notch
signalling in cancer cells. EMBO J. 30:770–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Ma J, Cheng L, Liu H, Zhang J, Shi Y, Zeng
F, Miele L, Sarkar FH, Xia J and Wang Z: Genistein down-regulates
miR-223 expression in pancreatic cancer cells. Curr Drug Targets.
14:1150–1156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng
L, Shi Y, Wang H, Yin B, Xia J and Wang Z: Down-regulation of
miR-223 reverses epithelial-mesenchymal transition in
gemcitabine-resistant pancreatic cancer cells. Oncotarget.
6:1740–1749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Prueitt RL, Yi M, Hudson RS, Wallace TA,
Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, et al:
Expression of microRNAs and protein-coding genes associated with
perineural invasion in prostate cancer. Prostate. 68:1152–1164.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Mees ST, Mardin WA, Sielker S, Willscher
E, Senninger N, Schleicher C, Colombo-Benkmann M and Haier J:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2350. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Zhang B, Guo X, Zhang J, Liu X, Zhan X and
Li Z: MicroRNA224 is downregulated in mucinous cystic neoplasms of
the pancreas and may regulate tumorigenesis by targeting Jagged1.
Mol Med Rep. 10:3303–3309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Maniati E, Bossard M, Cook N, Candido JB,
Emami-Shahri N, Nedospasov SA, Balkwill FR, Tuveson DA and Hagemann
T: Crosstalk between the canonical NF-κB and Notch signaling
pathways inhibits Pparγ expression and promotes pancreatic cancer
progression in mice. J Clin Invest. 121:4685–4699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Audas TE and Lee S: Stressing out over
long noncoding RNA. Biochim Biophys Acta. 1859:184–191. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Hang Q, Sun R, Jiang C and Li Y: Notch 1
promotes cisplatin-resistant gastric cancer formation by
upregulating lncRNA AK022798 expression. Anticancer Drugs.
26:632–640. 2015.PubMed/NCBI
|
|
86
|
He Y, Meng XM, Huang C, Wu BM, Zhang L, Lv
XW and Li J: Long noncoding RNAs: Novel insights into hepatocelluar
carcinoma. Cancer Lett. 344:20–27. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Tang J, Zhuo H, Zhang X, Jiang R, Ji J,
Deng L, Qian X, Zhang F and Sun B: A novel biomarker Linc00974
interacting with KRT19 promotes proliferation and metastasis in
hepatocellular carcinoma. Cell Death Dis. 5:e15492014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ebbesen KK, Kjems J and Hansen TB:
Circular RNAs: Identification, biogenesis and function. Biochim
Biophys Acta. 1859:163–168. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Li J, Yang J, Zhou P, Le Y, Zhou C, Wang
S, Xu D, Lin HK and Gong Z: Circular RNAs in cancer: Novel insights
into origins, properties, functions and implications. Am J Cancer
Res. 5:472–480. 2015.PubMed/NCBI
|
|
91
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Zhao ZJ and Shen J: Circular RNA
participates in the carcinogenesis and the malignant behavior of
cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Xie H, Ren X, Xin S, Lan X, Lu G, Lin Y,
Yang S, Zeng Z, Liao W, Ding YQ and Liang L: Emerging roles of
circRNA_001569 targeting miR-145 in the proliferation and invasion
of colorectal cancer. Oncotarget. 7:26680–26691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Li P, Chen S, Chen H, Mo X, Li T, Shao Y,
Xiao B and Guo J: Using circular RNA as a novel type of biomarker
in the screening of gastric cancer. Clin Chim Acta. 444:132–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wang X, Zhang Y, Huang L, Zhang J, Pan F,
Li B, Yan Y, Jia B, Liu H, Li S and Zheng W: Decreased expression
of hsa_circ_001988 in colorectal cancer and its clinical
significances. Int J Clin Exp Pathol. 8:16020–16025.
2015.PubMed/NCBI
|
|
97
|
Qin M, Liu G, Huo X, Tao X, Sun X, Ge Z,
Yang J, Fan J, Liu L and Qin W: Hsa_circ_0001649: A circular RNA
and potential novel biomarker for hepatocellular carcinoma. Cancer
Biomark. 16:161–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Shang X, Li G, Liu H, Li T, Liu J, Zhao Q
and Wang C: Comprehensive circular RNA profiling reveals that
hsa_circ_0005075, a new circular RNA Biomarker, is involved in
hepatocellular crcinoma development. Medicine (Baltimore).
95:e38112016. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yamamoto H, Toyooka S, Maki Y, Soh J and
Miyoshi S: Significance of noncoding RNA in surgery: Noncoding RNA
in lung cancer. Nihon Geka Gakkai Zasshi. 116:374–377. 2015.(In
Japanese). PubMed/NCBI
|
|
100
|
Palagani V, Bozko P, El Khatib M, Belahmer
H, Giese N, Sipos B, Malek NP and Plentz RR: Combined inhibition of
Notch and JAK/STAT is superior to monotherapies and impairs
pancreatic cancer progression. Carcinogenesis. 35:859–866. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Pei J and Wang B: Notch-1 promotes breast
cancer cells proliferation by regulating LncRNA GAS5. Int J Clin
Exp Med. 8:14464–14471. 2015.PubMed/NCBI
|
|
102
|
Trimarchi T, Bilal E, Ntziachristos P,
Fabbri G, Dalla-Favera R, Tsirigos A and Aifantis I: Genome-wide
mapping and characterization of Notch-regulated long noncoding RNAs
in acute leukemia. Cell. 158:593–606. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Li F, Zhang L, Li W, Deng J, Zheng J, An
M, Lu J and Zhou Y: Circular RNA ITCH has inhibitory effect on ESCC
by suppressing the Wnt/β-catenin pathway. Oncotarget. 6:6001–6013.
2015. View Article : Google Scholar : PubMed/NCBI
|
